Skip to content
Info for Health Care Providers
In-Lab Screening Using NIPT NIPT Sendout for Labs NIPT Education for Labs Info for Health Care Providers Resources for NIPT Sendout Labs

Experts on NIPT

Patients and peers support use of NIPT

 
 
Illumina Genomics Podcast Episode 31: Noninvasive Prenatal Testing — NIPT

Dr. Wapner, Vice Chair of Research in Obstetrics and Gynecology for Columbia University, shares his perspective on prenatal screening and NIPT.

Listen Now

Hear from patients about NIPT

Paola and Murray share how NIPT helped empower their journey through pregnancy.

 

See resources to help you get started with NIPT in your practice

Learn More

These pages are intended for healthcare professional audiences. Some solutions referenced in this content may not be available or approved in specific geographies.

For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.